. Recently, evidence of a severe form of inherited PD has been found that results in cellular dysfunction and breakdown not just in the dopaminergic neurons but also in neurons located in other areas of the brain. This condition has been termed Parkinsonpyramidal syndrome (PPS) and has been described to result in a severe and precocious form of disease (Rajendran et al. 2000) . Like traditional models of PD, PPS acts by damaging neurons in specific areas of the mid-brain to cause movement dysfunction and, eventually, cognitive decline. Unlike traditional models of PD, PPS affects neurons in the pyramidal area of the brain leading to direct loss of muscle control and symptoms that present earlier than other forms of PD (Lai et al. 2012) . Mutation of the FBXO7 gene has been implicated in the pathology of this extreme form of PD (Di Fonzo et al. 2009 ). Although specific mutations have been isolated that lead to this disease phenotype, the mechanisms behind this system and why these mutations lead to a parkinsonian phenotype have yet to be determined. D r a f t as differentiation, DNA quality control, circadian rhythm and neuronal synapse formation (Merzetti 2013) . Evidence of intra-cellular proteinaceous inclusions in FBXO7 forms of PPS suggest that breakdown of the proteasomal machinery may be a direct result of mutation in this gene (Zhao et al. 2013) . A decrease in the concentration of FBXO7 protein in the nucleus of neuronal cells correlates with an onset of PD phenotypes.
Structurally, FBXO7 contains an F-box motif (residues 329-375) which interacts with Skp1 (Cenciarelli et al. 1999) . Interaction with the E2-ubiquitin conjugating enzyme occurs at the N-terminal ubiquitin-like domain. The specificity of this protein comes from a proline-rich region (PRR) at the C-terminus which does not possess a defined secondary structure. Substrates of the SCF complex bind to this C-terminal PRR to hasten ubiquitination (Chang et al. 2006) . FBXO7 is differentially expressed throughout the brain and recent evidence has shown that FBXO7 interacts with PARKIN and PINK1 in vivo to mediate proper mitochondrial function (Burchell et al. 2013) . Furthermore, FBXO7 is highly expressed in regions of the brain associated with PD including the cerebral cortex, globus pallidus and substantia nigra (Nelson et al. 2013) . The function of FBXO7 relies upon stabilization by a binding partner. Originally named for its inhibition of the 20S proteasome (Chu-Ping et al. 1992), proteasomal-inhibitor-31 (PI31) interacts with FBXO7 through a shared N-terminal region aptly named the FBXO7/PI31 (FP) domain (Kirk et al. 2008) . Despite its original identification as a proteasomal inhibitor, it appears as if PI31 acts as an activator of the 26S proteasome through stabilization of the SCF complex.
D. melanogaster has proven to be a convenient model organism for the study of human disease in vivo. An abundance of genetic tools, access to the complete genome and a quick generation time make flies an ideal system to study specific disease linked genes. Furthermore, D r a f t D. melanogaster has been extensively used as a model neurological system due to similar complexity of neurons and neurotransmitter systems compared to higher organisms (Bilen and Bonini 2005) . A potential D. melanogaster homologue of FBXO7 has been identified. This gene, termed nutcracker (ntc), shares sequence similarity to FBXO7 within the F-box domain and has been shown to function in pathways of proteolysis (Bader et al. 2011) . Initially, ntc was implicated to play a role in the terminal differentiation of male germ cells, a process that relies heavily upon proteasomal machinery (Bader et al. 2010) . Disruption of ntc directly leads to a reduction in proteasome activity without reducing proteasomal machinery. This indicates that disruption of the proteolytic cascade occurs at protein ubiquitination when ntc is dysfunctional.
Thus ntc seems to play the same role as an E3 ubiquitin ligase in D. melanogaster as FBXO7 does in mammals.
A D. melanogaster homologue of PI31 has been studied as a regulator of ubiquitin mediated proteolysis. In cells where mutation of PI31 is present there is a marked accumulation of poly-ubiquitinylated proteins, indicating a defective proteasome (Bader et al. 2011 ). This phenotype can be rescued by moderate overexpression of the wild type PI31 protein but a high level of expression or a complete loss of function in PI31 lead to lethal phenotypes. This indicates that PI31 is tightly regulated and important for proper cellular function. Furthermore, cells expressing a mutation in the FP binding domain show similar phenotypes to PI31 null mutants (Bader et al. 2011 The eyes of mounted flies were imaged via scanning electron micrography at 130 times magnification with a Mineral Liberation Analyzer 650F scanning electron microscope.
Ommatidia and bristle counts were performed and annotated using ImageJ (Schneider et al. 2012 the Y-intercept remained constant across all groups, it was necessary that both parameters were incorporated into statistical analysis to determine differences in climbing ability. A comparison of fits concluded whether there was a significant difference between data groups. and carried out this experiment at both 25°C and 29°C; the latter is typically utilized to produce a greater level of activity due to the Gal4-UAS systems increased performance at higher temperatures.
Results

FBXO7
Tissue specific expression of the UAS-ntc transgene caused a similar and significant decrease in the number of ommatidia at both 25°C and 29°C. The difference between the two conditions was not significant, indicating the potential existence of a threshold above which further extension of gene activity no longer has an effect on ommatidia number ( Figure 2A ).
Alternatively, the number of bristles was significantly reduced at 25°C with a more severe phenotype found at 29°C ( Figure 2B ). Tissue specific expression of ntc-RNAi caused a significant decrease in both ommatidia and bristle numbers at 25°C and a similar, yet more severe, rough eye phenotype at 29°C.
Expression of PI31 in the D. melanogaster eye causes a significant decrease in the number of ommatidia formed compared to lacZ controls ( Figure 3A ). This effect is consistent at both 25°C and 29°C with the latter producing a more severe phenotype, showing that higher expression continues to negatively impact neuronal formation. Tissue specific expression of -PI31-RNAi caused a significant reduction in ommatidia and bristle numbers at 25°C and a glossylike eye phenotype at 29°C, this may indicate that PI31 is more tightly regulated in the D.
melanogaster eye, especially at higher levels of expression, than ntc. melanogaster.
Inhibition of ntc increases the mean longevity of D. melanogaster when co-expressed with α-synuclein
Ectopic expression of human α-synuclein in D. melanogaster has been shown to produce disease-modelling phenotypes including impaired locomotor function and tissue disruption (Feany and Bender 2000) . Altered activity of ntc or PI31, along with α-synuclein in the dopaminergic neurons, was assayed to investigate the potential to influence these phenotypes.
Dopaminergic expression of a ntc-RNAi construct increases median lifespan compared to a lacZ control in an α-synuclein background ( Figure 5A ). This indicates that expression of ntcRNAi in an α-synuclein background has a positive effect in dopaminergic neurons. However, despite this increase in mean lifespan, locomotor climbing assays indicate that there is no D r a f t significant difference in time between when these flies lose their climbing ability ( Figure 5B ).
This indicates that although the mean lifespan of ntc-RNAi flies is longer in a PD background, the motor ability of these organisms may be compromised earlier in overall lifespan than in lacZ controls.
Dopaminergic PI31-RNAi expression in an α-synuclein background leads to a severe and significant decrease in longevity compared to lacZ controls ( Figure 5C ). Flies expressing both α-synuclein and PI31-RNAi live only about 60% as long as α-synuclein and lacZ expressing controls. Expression of PI31 causes no significant difference in mean lifespan compared to a lacZ control. Additionally, there is no significant difference in the locomotor climbing ability of flies expressing both PI31 and PI31-RNAi in an α-synuclein background ( Figure 5D ).
Discussion
Mammalian FBXO7 functions as an E3 ubiquitin ligase, the targeting sub-unit of a multicomponent proteasomal system responsible for recognizing and destroying damaged or dysfunctional proteins in the cell. Mutations in FBXO7 has been identified as the cause of a particularly severe form of PD (Lai et al. 2012 (Randle et al. 2015) . Decreased longevity associated with expression of UAS-ntc may be due to an increase in proteasome activity, potentially causing non-specific degradation of target proteins. Direct interaction of FBXO7 and PARKIN has been found in human cells, this interaction has been shown to be important in the process of mitophagy (Burchell et al. 2013) . FBXO7 and ntc appear to share a similar role in mammals and D.
melanogaster respectively with regard to neuronal cell function and development.
Altered activity of PI31 causes decreased viability of neurons. Expression of either a UAS-PI31 or a PI31-RNAi transgene lead to developmental defects in both the ommatidia and bristles of the eye and reduced longevity when expressed directly in dopaminergic neurons.
PI31 appears to be tightly regulated in both tissues as either increased or decreased expression leads to severe negative consequences. This effect has been previously characterized in the D.
melanogaster eye by Bader et. al. (Bader et al. 2011) , however, we are the first to look at the effect of altered PI31 expression in dopaminergic neurons. Although PI31 acts as a stabilizing protein in the SCF ubiquitin ligase complex, it has also been characterized as a direct binding inhibitor of the 20S proteasome complex (Li et al. 2014) . Two separate areas of the PI31 protein are responsible for this activity with the C-terminal region binding to FBXO7 and the N-terminal region binding to the 20S proteasome (Kirk et al. 2008) . It is possible that a decrease in the amount of PI31 reduces the efficiency of the SCF proteasome complex due to de-stabilization while an increase in PI31 leads to inhibition of proteasome machinery via direct binding of extra PI31 to the proteasome itself.
D r a f t
Mutation of the SNCA gene leads to the accumulation of harmful protein aggregates of mis-folded α-synuclein known as Lewy Bodies (Spillantini et al. 1998 Co-expression of ntc-RNAi and α-synuclein in dopaminergic neurons lead to a significant increase in lifespan compared to controls. However, despite benefitting from increased longevity flies expressing both ntc-RNAi and α-synuclein lose their climbing ability at the same time as α-synuclein-expressing control flies indicating that although they live longer they suffer from impaired locomotor control. Decreased ntc activity by the expression of ntc-RNAi may lead to lowered activity of the SCF ubiquitin proteasome. It is possible that this diminished proteasome activity could reduce the amount of cell death occurring, leaving unhealthy neurons containing intra-cellular inclusions that could in turn cause locomotor defects. This could explain why longevity is increased but climbing ability is not significantly different from controls.
Alternatively, a decrease in ntc coupled with the presence of intra-cellular inclusions caused by ectopic α-synuclein expression could lead to a protein stress response which has been linked to increased lifespan in flies (Houtkooper et al. 2013) . The exact mechanism of this protein
response is yet unknown, however, it may be triggered by the low level presence of reactive 
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